Billions in Planned Investments Are Being Delayed, Reduced, or Redirected as Pharmaceutical Companies Reassess Europe’s Competitiveness.
For decades, Europe has been one of the world's leading destinations for pharmaceutical research, manufacturing, and innovation. Germany has long been regarded as the manufacturing powerhouse of the European pharmaceutical industry, while the United Kingdom has served as a global center for life sciences research and drug development.